atenolol has been researched along with Acidosis, Renal Tubular Type IV in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Excerpt | Relevance | Reference |
---|---|---|
"Hypoaldosteronism is a clinical condition resulting from inadequate stimulation of aIdosterone secretion (hyporeninemic hypoaIdosteronism), defects in adrenal synthesis of aldosterone (hyperreninemic hypoaldosteronism), or resistance to the peripheral action of this hormone (pseudohypoaldosteronism)." | 1.38 | [Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2]. ( Krysiak, R; Okopień, B, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krysiak, R | 1 |
Okopień, B | 1 |
1 other study available for atenolol and Acidosis, Renal Tubular Type IV
Article | Year |
---|---|
[Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2].
Topics: Adult; Atenolol; Female; Fludrocortisone; Humans; Hypoaldosteronism; Ibuprofen; Mineralocorticoids; | 2012 |